Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of artificial intelligence in peptide vaccine design against RNA viruses
Eileena Mohanty, Anima Mohanty
Informatics in Medicine Unlocked (2021) Vol. 26, pp. 100768-100768
Open Access | Times Cited: 22

Showing 22 citing articles:

Development and use of machine learning algorithms in vaccine target selection
Barbara Bravi
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
Zhao Song, Junhao Luo, Wenhui Guo, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 81-81
Open Access | Times Cited: 1
mRNA therapeutics: New vaccination and beyond
Huanhuan Wei, Liangliang Zheng, Zefeng Wang
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 749-759
Open Access | Times Cited: 31
Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones
Iosif Tammas, Konstantina Bitchava, Athanasios Ι. Gelasakis
Vaccines (2024) Vol. 12, Iss. 7, pp. 732-732
Open Access | Times Cited: 6
The Applications of Artificial Intelligence (AI)-Driven Tools in Virus-Like Particles (VLPs) Research
Bugude Laxmi, P. Uma Maheswari Devi, Naveen Thanjavur, et al.
Current Microbiology (2024) Vol. 81, Iss. 8
Closed Access | Times Cited: 4
Vaccine design and development: Exploring the interface with computational biology and AI
Ananya Ananya, Darshan C. Panchariya, Anandakrishnan Karthic, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 6, pp. 361-380
Closed Access | Times Cited: 4
Personalized cancer vaccine design using AI-powered technologies
Anant Kumar, Shriniket Dixit, Kathiravan Srinivasan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Discovering conserved epitopes of Monkeypox: Novel immunoinformatic and machine learning approaches
Mohammad Izadi, Fatemeh Mirzaei, Mohammad Aref Bagherzadeh, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24972-e24972
Open Access | Times Cited: 3
Innovative Ecosystem Model of Vaccine Lifecycle Management
Igor Ilin, Anastasia Levina, Konstantin Frolov
Journal of Open Innovation Technology Market and Complexity (2022) Vol. 8, Iss. 1, pp. 5-5
Open Access | Times Cited: 13
VacSol-ML(ESKAPE): Machine learning empowering vaccine antigen prediction for ESKAPE pathogens
Samavi Nasir, Farha Anwer, Zaara Ishaq, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126204-126204
Closed Access | Times Cited: 1
Internet of Things and Machine Learning for Smart Healthcare
Cristiano André da Costa, Felipe André Zeiser, Rodrigo da Rosa Righi, et al.
Studies in computational intelligence (2024), pp. 95-133
Closed Access | Times Cited: 1
Future Prospects and Challenges in the Implementation of AI and ML in Pharma Sector
Prashant Pokhriyal, Vivek P. Chavda, Mili Pathak
(2023), pp. 401-416
Closed Access | Times Cited: 4
Identification and evaluation in-vitro of conserved peptides with high affinity to MHC-I as potential protective epitopes for Newcastle disease virus vaccines
Luis Tataje‐Lavanda, Edith Málaga, Manuela Verástegui, et al.
BMC Veterinary Research (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Artificial intelligence channelizing protein-peptide interactions pipeline for host-parasite paradigm in IL-10 and IL-12 reciprocity by SHP-1
Shweta Khandibharad, Shailza Singh
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 10, pp. 166466-166466
Open Access | Times Cited: 6
Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine
Ashraf A. Tabll, Sayed Sartaj Sohrab, Ahmed Ali, et al.
Pathogens (2023) Vol. 13, Iss. 1, pp. 38-38
Open Access | Times Cited: 3
Discussing the Future Perspective of Machine Learning and Artificial Intelligence in COVID-19 Vaccination: A Review
Rita Roy, Kavitha Chekuri, Jammana Lalu Prasad, et al.
Springer proceedings in mathematics & statistics (2023), pp. 151-160
Closed Access | Times Cited: 2
Application of Artificial Intelligence Algorithms in Mathematical Modeling Optimization Research
Qiao Zeng
Lecture notes in electrical engineering (2024), pp. 103-112
Closed Access
The power of AI in viral vaccine production: A paradigm shift in efficiency and costs
Bappi Sarkar
Methods in microbiology (2024)
Closed Access
In silico identification and ex vivo evaluation of Toxoplasma gondii peptides restricted to HLA-A*02, HLA-A*24 and HLA-B*35 alleles in human PBMC from a Colombian population
Mónica Vargas Montes, María Camila Valencia-Jaramillo, Juan David Valencia Hernández, et al.
Medical Microbiology and Immunology (2024) Vol. 214, Iss. 1
Open Access
Designing of a Novel Candidate Multi-epitope Vaccine to boost Immune Responses against SARS‐COV‐2 using Immunoinformatics and Machine Learning based Approach
Shiva Mohammadi, Soudabe Kavusi Pour, Sajad Jalili, et al.
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 2, pp. 356-375
Closed Access | Times Cited: 2
Editorial: RNA machines
Nikolay E. Shirokikh, Kirk B. Jensen, Nehal Thakor
Frontiers in Genetics (2023) Vol. 14
Open Access
Vaccines and Neglected Tropical Diseases: a complicated challenge or a postpandemic hope
Juan García-Bernalt Diego, Raúl Manzano-Román, Antonio Muro
Anales de la Real Academia Nacional de Farmacia (2022) Vol. 88, Iss. 88(05), pp. 565-577
Open Access
Page 1

Scroll to top